Skip to main content Skip to main navigation menu Skip to site footer

Silver sulfadiazine as the topical treatment for giant omphalocele: a case report

  • Ni Luh Putu Herli Mastuti ,
  • Risa Etika ,
  • Martono Tri Utomo ,
  • Dina Angelika ,
  • Kartika Darma Handayani ,

Abstract

Background: Major omphalocele is defined as an abdominal defect greater than 5 cm with the presence of the liver and most parts of the bowel in the sac. The management remains challenging for pediatricians and surgeons with remarkably high mortality. Reports about topical agents/dressing used as escharotic therapy, such as silver sulfadiazine, povidone-iodine, topical antibiotics, or honey, have been published with different results. Continued application of a thick layer of silver sulfadiazine on the omphalocele surface is needed to promote eschar formation and neo-epithelialization.

Case description: A term, 2700-gram newborn male infant presented with abdominal defect and herniated abdominal contents covered by a membranous sac containing liver that is widely known as omphalocele. A thick layer of silver sulfadiazine was applied repeatedly onto the omphalocele sac to promote epithelialization and successfully reduce the sac diameter. The patient showed a positive outcome as it reduced the omphalocele size after nine days. The patient family has been educated about the continued application of silver sulfadiazine. Although non-operative delayed treatment has lower mortality rates and better clinical outcomes, the patients should wait for the reconstruction surgery for a long time.

Conclusion: Conservative treatment with silver sulfadiazine is safe and shows satisfying results to the giant omphalocele.

References

  1. Pakhale S. A Rare Anterior Abdominal Wall Defect: Omphalocele - A Case Report. Journal of Krishna Institute of Medical Sciences (JKIMSU). 2015;4(1):172-176.
  2. Osifo D, Ovueni ME, Evbuomwan I. Omphalocele Management using Goal-oriented Classification in African Centre with Limited Resources. 2011;57(4):286–288.
  3. Bielicki IN, Somme S, Frongia G, Holland-Cunz SG, Vuille-Dit-Bille RN. Abdominal Wall Defects-Current Treatments. Children (Basel). 2021;8(2):170.
  4. Hamid R, Mufti G, Wani SA, Ali I, Na B, Baba AA, et al. Importance of the Early Management of Omphalocele Minor. Journal of Neonatal Biology. 2015;4(2):1-4.
  5. Bauman B, Stephen D, Gershone H, Bongiorno C, Osterholm E, Acton R, et al. management of giant omphaloceles: A systemic review of methods of staged surgical vs. non-operative delayed closure. J Pediatr Surg. 2016;51(10):1725–1730.
  6. Gasser RF, Cork RJ, Stillwell BJ, McWilliams DT. Rebirth of human embryology. Dev Dyn. 2014;243(5):621-628.
  7. Poaty H, Pelluard F, Diallo MS, Patricia I, Ondima L, André G, et al. Omphalocele: a review of common genetic etiologies. Egyptian Journal of Medical Human Genetics. 2019;20(37):1-6.
  8. Haldipur P, Dang D, Millen KJ. Embryology. Handb Clin Neurol. 2018;154:29-44.
  9. Verla MA, Style CC, Olutoye O. No TitlPrenatal diagnosis and management of omphalocelee. Semin Pediatr Surg. 2019;28(2):84–88.
  10. Ein SH, Langer JC. Delayed management of giant omphalocele using silver sulfadiazine cream: An 18-year experience. Journal of Pediatric Surgery. 2012;47(3):494–500.
  11. Lakshminarayanan B, Lakhoo K. Abdominal wall defects. Early Hum Dev. 2014;90(12):917-920.
  12. Adeniran JO, Nasir AA, Abdur-Rahman L. Should Omphaloceles be Re-classified. East Cent Afr J Surg. 2011;16(2):25–31.
  13. Ekot EA, Emordi VC, Osifo DO. Does omphalocele major undergo spontaneous closure?. J Surg Case Rep. 2017;2017(8):rjx156.
  14. Lee SL, Beyer TD, Kim SS, Waldhausen JHT, Healey PJ, Sawin RS, et al. Initial non-operative management and delayed closure for treatment of giant omphaloceles. Journal of Pediatric Surgery. 2006;41(11):1846–1849.
  15. Rattan KN, Singh J, Jakhar R, Dalal P, Sonika P. Omphalocele: 15-Years Experience from a Single Center in Developing Country. Journal of Clinical Neonatology. 2018;7(3):125–129.
  16. Kogut KA, Fiore NF. Nonoperative management of giant omphalocele leading to early fascial closure. J Pediatr Surg. 2018;53(12):2404-2408.
  17. Rattan KN, Singh J, Dalal P, Rohilla R. Conservative management of giant omphalocele: 20-year experience from a tertiary care center in North India. Journal of Pediatric and Neonatal Individualized Medicine. 2020;9(1):e090105-e090105.
  18. Dörterler ME. Management of Giant Omphalocele Leading to Early Fascial Closure. Cureus. 2019;11(10):e5932.
  19. Pandey V, Gangopadhyay AN, Gupta DK, Sharma SP, Kumar V. Non-operative management of giant omphalocele with topical povidone-iodine and powdered antibiotic combination: early experience from a tertiary centre. Pediatr Surg Int. 2014;30(4):407–411.
  20. Eltayeb AA, Mostafa MM. Topical treatment of major omphalocoele: Acacia nilotica versus povidone-iodine: A randomised controlled study. Afr J Paediatr Surg. 2015;12(4):241-246.
  21. Nicoara CD, Singh M, Jester I, Reda B, Parikh DH. Medicated Manuka honey in conservative management of exomphalos major. Pediatr Surg Int. 2014;30(5):515–520.
  22. Wen X, Zheng Y, Wu J, Yue L, Wang C, Luan J, et al. In vitro and in vivo investigation of bacterial cellulose dressing containing uniform silver sulfadiazine nanoparticles for burn wound healing. Progress in Natural Science: Materials International. 2015;25(3):197–203.
  23. Akkam AY, Joarder A, Cruz-Marcelino N, Mitra B, Alshehri S, Almazroua F. Epidemiology of pediatric patients admitted to a burns ICU in Saudi Arabia. Burns Open. 2020;4(3):90–93.
  24. Muhammad K, Prasetyo A, Prajoko YW, Najatullah N, Susilaningsih N. Effectiveness of nanosilver collagen cream for healing deep dermal burns in Sprague Dawley rats: an overview of neutrophil counts and angiogenesis. Bali Medical Journal. 2021;10(2):648–652.
  25. Handayani E, Masithoh RF. A small-scale re-evaluation of the efficacy of silver sulfadiazine for burns. Br J Community Nurs. 2020;25(Sup12):S34-S38.
  26. Adhya A, Bain J, Dutta G, Hazra A, Majumdar B, Ray O, et al. Healing of burn wounds by topical treatment: A randomized controlled comparison between silver sulfadiazine and nano-crystalline silver. Journal of Basic and Clinical Pharmacy. 2015;6(1):29-34.
  27. Muliarta M, Tirtayasa K, Prabawa IPY, Wiryadana KA. Tamarillo Consumption Associated with Increased Acetylcholinesterase Activity and Improved Oxidative Stress Markers in Farmers Exposed to Daily Pesticide-related Activities in Baturiti, Bali, Indonesia. Open Access Maced J Med Sci. 2020;8(E):244-250.

How to Cite

Mastuti, N. L. P. H. ., Etika, R. ., Utomo, M. T., Angelika, D. ., & Handayani, K. D. . (2022). Silver sulfadiazine as the topical treatment for giant omphalocele: a case report. Bali Medical Journal, 12(1), 59–63. https://doi.org/10.15562/bmj.v12i1.3620

HTML
6

Total
1

Share

Search Panel

Ni Luh Putu Herli Mastuti
Google Scholar
Pubmed
BMJ Journal


Risa Etika
Google Scholar
Pubmed
BMJ Journal


Martono Tri Utomo
Google Scholar
Pubmed
BMJ Journal


Dina Angelika
Google Scholar
Pubmed
BMJ Journal


Kartika Darma Handayani
Google Scholar
Pubmed
BMJ Journal